Targeting the PI3K/AKT signaling pathway in anticancer research: a recent update on inhibitor design and clinical trials (2020 –2023)

.

Source: Expert Opinion on Therapeutic Patents - April 9, 2024 Category: Drugs & Pharmacology Authors: Dima A. SabbahRima HajjoSanaa K. BardaweelHaizhen A. Zhonga Department of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman, Jordanb Laboratory for Molecular Modeling, Division of Chemical Biology and Medicinal Chemistry, Eshelman Sc Source Type: research